Skip to content
healthcare.dev
Get a free key

Deferasirox

NDC 62332-325, Deferasirox, tablet, for suspension, from Alembic Pharmaceuticals Inc..

Product NDC
62332-325
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210060
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-325 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX250 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
62332-325-306233203253030 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-325-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1f9f1a69-bf71-4e6a-88b0-90f08c4da79f

Use it

Look up 62332-325 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-325 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-325. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.